Anti-XIAP (MIHA/ILP-a) (Human) mAb

MBL
Product Code: MBL-M044-3
Product Group: Primary Antibodies
Supplier: MBL
CodeSizePrice
MBL-M044-3100 ug£341.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG1
Antibody Clonality: Monoclonal
Antibody Clone: 2F1
Regulatory Status: RUO
Target Species:
  • Human
  • Mouse
  • Rat
Applications:
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
4°C
Storage:
-20°C

Images

1 / 2
2 / 2

Documents

Further Information

Applications:
WB - 1 ug/mL (chemiluminescence detection system)
Background:
Caspase, related to ICE and to CED- 3, play central roles as effectors of apoptosis. Ablation of caspase activity is attained by p35 from baculovirus and CrmA from cowpox, which appear to be suicide inactivators, strongly inhibiting caspase activity. Overexpression of there caspase inhibitors in insect, nematoda and mammalian cells results in resistance to apoptotic stimuli, demonstrating that components of the apoptotic pathway are highly conserved throughout evolution, and leading to the speculation that mammalian functional equivalents of these protease inhibitors may exist. The inhibitor of apoptosis proteins (IAPs) are a family of anti-apoptotic proteins that are conserved across species. Four IAPs have been identified in mammal; NAIP, cIAP1/HIAP2/hMIHB, cIAP2/HIAP1/hMIHC, XIAP/hILP. A prototype of the human IAPs is the XIAP, with a 1.5 kb coding region corresponding to a 55 kDa protein. XIAP can directly inhibit two members of the cell death protease family, caspase-3 and -7.
Concentration:
1 mg/mL
Formulation:
1.0 mg/mL in PBS/50% glycerol, pH 7.2
Gene IDs:
Human: 331 Mouse: 11798
Immunogen Translated:
Full-length recombinant human XIAP protein
Reactivity:
This antibody reacts with XIAP on Western blotting. 2F1 recognizes C-terminal region of XIAP (352-449 aa) and detects 55 kDa of XIAP on Western Blot using total cell lysate from human or mouse cell line, for example, Jurkat, Raji, NIH/3T3, etc.
Shelf Life:
1 year
Source:
This antibody was purified from hybridoma (clone 2F1) supernatant using protein A agarose. This hybridoma was established by fusion of mouse myeloma cell P3U1 with Balb/c mouse splenocyte immunized with the full length recombinant XIAP protein (1-497 aa).
Target:
XIAP

References

1) Cillessen, S. A., et al., Clin. Cancer Res. 13, 7012-7021 (2007) 2) Marsden, V. S., et al., Blood 107, 1872-1877 (2006) 3) Tanaka, H., et al., J. Biol. Chem. 280, 40965-40973 (2005) 4) Muris, J.J., et al., Blood 105, 2916-2923 (2005) 5) Silke, J., et al., PNAS. 102, 16182-16187 (2005) 6) Silke, J., et al., J. Biol. Chem. 279, 4313-4321 (2004) 7) Park, S-J., et al., J. Biol. Chem. 279, 51057-51067 (2004) 8) Ferreira, C. G., et al., Clin. Cancer Res. 7, 2468-2474 (2001) 9) Ferreira, C. G., et al., Ann. Onc. 12, 799-805 (2001) 10) Li, J., et al. Endocrinology 139, 1321-1328 (1998) 11) Farahani, R., et al. Genomics 42, 514-518 (1997) 12) Roy, N., et al., EMBO J. 16, 6914-6925 (1997) 13) Deveraux, QL., et al. Nature 388, 300-304 (1997) 14) Liston, P., et al. Nature 379, 349-353 (1996)